scholarly article | Q13442814 |
P356 | DOI | 10.1097/MRR.0000000000000146 |
P698 | PubMed publication ID | 26579698 |
P50 | author | Alberto Raggi | Q37830338 |
Stefania Corti | Q42624238 | ||
Matilde Leonardi | Q56936660 | ||
Paolo Capodaglio | Q56984591 | ||
Valentina Villa | Q57321691 | ||
Amelia Brunani | Q92512095 | ||
Anna Sirtori | Q114413322 | ||
Maria Elisa Berselli | Q114413323 | ||
Francesca Ceriani | Q114413324 | ||
ICF-OBESITY Group | Q114413325 | ||
P433 | issue | 1 | |
P921 | main subject | obesity | Q12174 |
comorbidity | Q1414874 | ||
P304 | page(s) | 63-69 | |
P577 | publication date | 2015-11-17 | |
P1433 | published in | International Journal of Rehabilitation Research | Q15766041 |
P1476 | title | Patients with obesity-related comorbidities have higher disability compared with those without obesity-related comorbidities: results from a cross-sectional study | |
P478 | volume | 39 |
Q89288218 | A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss |
Q57791106 | Defining the appropriate setting for treating obese patients: do we have the right tools? |
Q64232819 | Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity |
Q91816915 | Investigating the Role of Myeloperoxidase and Angiopoietin-like Protein 6 in Obesity and Diabetes |
Search more.